Why the FDA should NOT have granted approval for roll-out in the 6 month to 4 yr old children

First published at 12:37 UTC on June 26th, 2022.

Dr Clare Craig explains why the FDA should NOT have granted approval for roll-out in the 6 month to 4 yr old children cohort

This trial should have been deemed null and void.

The regulators are failing to do their job.

CategoryEducation
SensitivityNormal - Content that is suitable for ages 16 and over
DISCUSS THIS VIDEO